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Abstract: 
 
The immune system has a well-established contribution to tissue homeostasis and wound 
healing. However, in many cases immune responses themselves can cause severe tissue 
damage. Thus, the question arose to which extent cells of the immune system directly 
contribute to the process of wound healing and to which extent the resolution of excessive 
immune responses may indirectly contribute to wound healing. FoxP3 expressing CD4 T-
cells, so-called regulatory T-cells (Tregs), have an important contribution in the regulation of 
immune responses; and, in recent years, it has been suggested that Tregs next to an immune 
regulatory, “damage-limiting” function may also have an immune independent, “damage-
resolving” direct role in wound healing. In particular, the release of the EGF-like growth 
factor Amphiregulin by tissue-resident Tregs during wound repair suggested such a function. 
Our recent findings have now revealed that Amphiregulin induces the local release of bio-
active TGFβ, a cytokine involved both in immune regulation as well as in the process of 
wound repair. In light of these findings, we discuss whether, by locally activating TGFβ, Treg-
derived Amphiregulin may contribute to both wound repair and immune suppression. 
Furthermore, we propose that Treg-derived Amphiregulin in an autocrine way may enable an 
IL-33 mediated survival and expansion of tissue-resident Tregs upon injury. Furthermore, Treg-
derived Amphiregulin may contribute to a constitutive, low-level release of bio-active TGFβ 
within tissues, leading to continuous tissue regeneration and to an immune suppressive 
environment, which may keep inflammation prone tissues in an homeostatic state. 
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Regulatory T-cells have an established role in wound healing: 
Following a breach of tissue homeostasis (be it by infection or tissue injury) a highly 
complex, but also well-orchestrated process of local inflammation occurs which guides local 
wound healing 1, 2. This process can roughly be separated into three distinct, consecutive but 
overlapping phases. These phases are traditionally divided into a pro-inflammatory initiation 
phase, a tissue formation phase and a resolution and tissue re-organisation phase 1. During 
each of these phases different types of leukocytes infiltrate the site of tissue damage and 
play distinct, clearly defined roles 1. The injury itself induces a pro-inflammatory initiation 
phase, during which neutrophils and pro-inflammatory monocytes are recruited to the site of 
injury 2. These cells contribute to host defence and the removal of cell debris and of necrotic 
cells. The pro-inflammatory initiation phase then transitions into the so-called tissue 
formation phase, in which inflammation is already dampened and a differentiation of 
infiltrating monocytes into alternatively activated macrophages occurs. During this phase, 
angiogenesis and cell proliferation lead to a closure of the wound. In the following, the so-
called resolution or tissue-remodelling phase, the immune response is actively suppressed 
and excessive tissue and cellular matrix growth is reversed 2. This process of wound healing 
has to be well orchestrated and disruption of this process, for instance due to the infection of 
the healing wound, can lead to a failure of wound healing or excessive scar formation 3.  
The transition from the pro-inflammatory initiation phase into the tissue formation phase and 
the resolution phase is critically controlled by immune regulatory mechanisms. In particular 
FoxP3-expressing regulatory CD4 T-cells (Tregs) appear to play a critical role in this 
transition. Tregs rapidly migrate to and accumulate at sites of inflammation, such as at sites of 
injury 4-6. Depletion of Tregs during the different phases of wound healing, for instance by the 
application of Diphtheria Toxin (DT) to FoxP3:DTR transgenic mice or by the injection of 
CD25-depleting antibodies, consistently led to aggravated inflammation and deteriorated 
clinical outcomes in a number of different injury model systems in mice 4, 6-12.  
For instance, in mouse models of myocardic infarction, the depletion of Tregs resulted in 
aggravated cardiac inflammation and deteriorated clinical outcome 9, 10. In these 
experiments, Treg-cell depletion was associated with increased neutrophil and monocyte 
infiltration and diminished alternatively-activated macrophage polarization 9. In contrast, 
expansion of the Treg compartment, for instance, via activation using super-agonistic anti-
CD28 monoclonal antibody administration 9 or adoptive Treg transfer 10, reduced infarct size 
and improved tissue remodelling and functional performance of the heart. Similarly, in 
mouse models of ischaemic-reperfused kidneys in Rag1-/- mice, the transfer of Tregs reduced 
the influx of neutrophils and macrophages, and diminished innate cytokine transcription in 
the kidney, resulting in diminished renal injury 7. Also in mouse models of muscle injury, 
such as in the mdx mouse model of Duchenne muscular dystrophy 11 or acute muscle injury 
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4, DTR-mediated depletion of Tregs in FoxP3:DTR transgenic mice exacerbated muscle injury 
and the severity of muscle inflammation, which was associated with a prolonged infiltration 
of pro-inflammatory monocytes and a bias towards classically-activated macrophages. In 
contrast, expansion of Tregs via the application of IL-2/anti-IL-2 complexes in mdx mice led to 
decreased myofiber injury and suppressed inflammation in muscles associated with muscle 
fiber injury 11. 
Thus, taken together, these findings clearly support the conclusion that Tregs critically 
contribute to the process of wound healing 
 
Immune-mediated roles of regulatory T-cells during wound healing: 
One of the underlying mechanisms associated with Treg-mediated wound healing is assumed 
to be the suppression of pro-inflammatory stimuli. Such Treg-mediated immune suppression 
appears to be a critical factor allowing for the progression of the wound healing process 13. 
Tregs utilize a number of different mechanisms to locally mediate their immune suppressive 
function 14. These mechanisms include the local activation of bio-active TGFβ 15, 16, the 
secretion of the immune suppressive cytokine IL-10 17 or the conversion of local adenosine 
monophosphate into adenosine 18. Accordingly, in mdx mice treated with IL-2/anti-IL-2 
complexes more Tregs and increased IL-10 concentrations were found in injured muscles 11. 
Also, in an ischaemic-reperfused kidney model and an experimental brain ischemia model in 
Rag1-/- mice, the adoptive transfer of wild-type, but not of IL-10-deficient Tregs, was sufficient 
to ameliorate tissue injury 7, 8. Furthermore, in a model of LPS-induced acute lung injury 
(ALI), the transfer of wild-type, but not of CD73-deficient Tregs ameliorated lung injury in 
Rag-/- mice; strongly suggesting that the CD73-mediated adenosine generation and thus 
induced immune suppression by Tregs contributed to the restoration of tissue homeostasis 19. 
Thus, the resolution of local inflammation is clearly a key function of Tregs during wound 
healing (Figure 1). 
 
 
Non-immune mediated roles of regulatory T-cells during wound healing: 
In recent years, it has further been suggested that Tregs may also directly contribute to wound 
healing, independent of their immune regulatory function 4, 20. Such a notion was supported 
by the discovery that in several different tissues, such as the muscle 4, a specific subtype of 
Tregs, so called tissue-resident Tregs 21, 22, expresses the EGF-like growth factor Amphiregulin.  
Amphiregulin is an EGF-like growth factor associated with a number of different 
physiological processes, such as tissue homeostasis, inflammation and immunity 23, 24. With 
regard to tissue homeostasis, a direct role for Amphiregulin has for instance recently been 
demonstrated for the gingiva 25. The gingiva is a key oral barrier site and Amphiregulin gene-
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deficient mice showed at steady state a substantially elevated level of oral, periodontal 
pathology in comparison to wild-type mice 25. Furthermore, during wound healing, a direct 
role of Amphiregulin has been suggested. For instance during infections, the injection of 
recombinant Amphiregulin (rAREG) has in several different experimental settings 
demonstrated the amelioration of symptoms, such as during Influenza infection 26, 27 or 
following viral-bacterial co-infections 28. In line with these findings, also during wound healing 
following muscle injury, the injection of rAREG enhanced the restoration of injured muscles 
and the presence of rAREG enhanced the differentiation of muscle stem cells in vitro. These 
findings were further corroborated by findings from the Rudensky group, using a mouse 
strain with a Treg-specific deficiency of Amphiregulin (FoxP3:cre x Aregfl/fl) 20. These mice 
showed a substantially more severe form of symptoms following Influenza infection than 
wild-type mice 20, suggesting a direct role of Treg-derived Amphiregulin in wound repair. 
Other studies further supported the finding that during wound healing Tregs may have, 
independent of immune modulatory function, a complementary, regenerative role. For 
instance, in a model of lysolecithin-mediated demyelination in the spinal cord of mice, Tregs 
were found to directly promote oligodendrocyte differentiation and myelin production 29. 
Depletion of Tregs led to a substantially impaired remyelination and oligodendrocyte 
differentiation, which could be reversed by the adoptive transfer of Tregs. In vitro studies then 
suggested that Treg-derived matricellular protein CCN3 - a protein known to induce the 
expression of TGFβ-related BMP proteins 30 - directly promoted oligodendrocyte progenitor 
cell differentiation and myelination 29. These data suggest that also in vivo Treg-derived CCN3 
may play a similar, wound healing supportive role in injured spinal cord tissue.  
In addition, in a study using established models of tissue regeneration in zebrafish, the 
conditional ablation of FoxP3 expressing zebrafish Tregs hampered organ regeneration 31. 
Dependent on the injured organ, infiltrating Tregs stimulated the proliferation of tissue 
precursor cells through the secretion of organ-specific regenerative factors, such as Ntf3 for 
the spinal cord, Nrg1 for the heart and Igf1 for the retina. Moreover, when Foxp3-deficient 
zebrafish Tregs infiltrated the injured organs, they failed to express regenerative factors and 
thus could not contribute to wound healing 31.  
Combined, these findings strongly suggest that Tregs, in addition to an immune modulatory, 
“damage-limiting” function, may also have a direct wound repair, “damage-resolving” 
function (Figure 1). 
 
The role of Amphiregulin in immune regulation and wound healing: 
The concept of such a double function of Tregs for “damage-limiting” and “damage-resolving” 
during wound healing is rather appealing. Nevertheless, a number of different findings 
suggest that, on a molecular level, the two functions might not easily be separable.  
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In mammalians the concept of a distinction of these two functions is mainly based on the 
finding that several types of tissue-resident Tregs express Amphiregulin and that the injection 
of rAREG supported the process of wound healing in several different model systems. 
However, the exact mechanism by which Amphiregulin contributes to wound healing had 
remained unresolved, while at the same time Amphiregulin had been shown before to 
enhance the suppressive capacity of Tregs in vitro and in vivo 32-36.  
We recently found that one critical function of Amphiregulin is to locally activate latent TGFβ 
37. Thus, via this local release of TGFβ, Amphiregulin may contribute to both the local 
suppression of inflammation as well as to the local differentiation of tissue stem cells and in 
this way to the process of wound healing and restoration of tissue homeostasis. In the 
following, we will discuss, how this novel insight may influence our understanding of Treg-
derived Amphiregulin for tissue homeostasis, wound repair and immune suppression. 
It has been well established that the receptor of Amphiregulin, the Epidermal Growth Factor 
Receptor (EGFR), contributes to wound healing 38. So far, it has mainly been assumed that 
this receptor mediates its function by inducing the proliferation of epithelial cells within the 
wound 38; and, in line with such an assumption, it has recent indeed been published from the 
group of Belkaid that a specific function for CD8 T-cell derived Amphiregulin is the induction 
of keratinocyte expansion within a healing skin wound 39. However, for many other epithelial 
and mesenchymal cell types, the low-affinity ligand of the EGFR Amphiregulin is actually not 
a particular good mitogen. In contrast to the high-affinity ligands of EGFR, such as EGF, 
TGFα or HB-EGF, which activate the proliferation-stimulating MAPK signalling pathway 40, 41, 
Amphiregulin preferentially induces the phosphorylation of EGFR-Y992 and thus the 
activation of PLCγ signalling pathway 42, 43. Thus, it is highly unlikely that Amphiregulin 
substantially contributes to wound healing by inducing the proliferation of epithelial cells at 
the site of wounding; and, thus, the underlying mechanism by which Amphiregulin 
contributes to wound healing has largely remained unresolved. 
We recently discovered that Amphiregulin induced the local activation of TGFβ 37. In mouse 
models of CCl4-induced acute liver damage and of Nippostrongylus infection-induced lung 
damage, we demonstrated that during wound healing Amphiregulin induced the TGFβ-
mediated differentiation of tissue stem cells and in this way critically contributed to the 
restoration of tissue homeostasis (Figure 2). TGFβ is secreted in a latent form and only by 
releasing it from this latent complex becomes the bio-active form of TGFβ exposed 44. One 
way of releasing bio-active TGFβ, is the activation of integrin-αV containing complexes 45. 
We found that Amphiregulin induced the activation of integrin-αV containing complexes and 
thus the local activation of TGFβ. This local activation of TGFβ induced the differentiation of 
blood vessel-associated mesenchymal precursor cells, so called pericytes, into collagen-
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producing myo-fibroblasts; a process, which critically contributed to the restoration of injured 
blood vessels and thus wound healing (Figure 2).  
A number of growth factors and chemokine receptors as well as the TCR use such an 
“inside-out” activation of integrin complexes to establish immunological synapsis between T-
cells and antigen-presenting cells 46 or to allow leukocytes to attach themselves to blood 
vessels in order to cross into inflamed tissues 47. A critical step in this “inside-out” activation 
of integrin complexes is the sustained activation of the PLCγ signalling pathway 48. 
Amphiregulin preferentially induces the PLCγ signalling pathway 42, 43 and is thus well 
situated to induce the activation of integrin-αV containing complexes on target cells, which 
then results in the release of bio-active TGFβ from its latent form (Figure 3). Thus, taken 
together, our data show that one major function of Amphiregulin is the local induction of 
TGFβ. 
 
Similar to Amphiregulin, also TGFβ has a double function during wound healing. For one, 
TGFβ induces the differentiation of tissue resident precursor cells; and, for the other, TGFβ 
is a key mediator of Treg-mediated immune suppression 15. To achieve TGFβ-mediated 
immune suppression, integrin-αV containing complexes on Tregs have to be activated, which 
then release bio-active TGFβ 16. A number of different groups have shown in in vitro 
suppression assays that rAREG enhances the suppressive capacity of Tregs 32, 34-36. Also in in 
vivo settings Amphiregulin enhances the suppressive capacity of Tregs 32, 33. For instance, in a 
T-cell transfer based colitis model, the titrated transfer of wild-type Tregs into Rag1-/- mice that 
had received naïve CD4 T-cells could in a dose-dependent manner suppress the induction 
of colitis, if the recipient Rag1-/- mice were on a wild-type background but not if the recipient 
Rag1-/- mice had been backcrossed onto an Amphiregulin-deficient background  32. 
Furthermore, following the adoptive transfer of antigen-specific Tregs, these cells could 
suppress hapten-induced ear swelling in wild-type, but not in Amphiregulin gene-deficient 
mice. These findings clearly demonstrated that endogenous expression of Amphiregulin is 
essential to ensure efficient Treg function. In line with this immune-suppressive function of 
Amphiregulin, it has been reported that also following ischaemic stroke Treg-derived 
Amphiregulin contributes to neurological recovery by suppressing IL-6 expression within the 
brain and thus avoiding neurotoxic astrogliosis 6. 
Although we so far have not yet formally addressed whether Amphiregulin also activates 
integrin-αV containing complexes on Tregs, our pericyte-based finding of Amphiregulin-
mediated TGFβ activation suggests that such a mechanism might also be the underlying 
effect by which Amphiregulin enhances Treg function 32. Nevertheless, in consequence, this 
TGFβ activating role of Amphiregulin also means that in those experimental settings, in 
which rAREG has been injected into mice, the injected rAREG may have induced the 
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release of bio-active TGFβ. This release of bio-active TGFβ may have enhanced the 
differentiation of tissue precursor cells, such as pericytes 37 or muscle satellite cells 4, and 
thus may have directly contributed to wound healing; or, at the same time, may have 
enhanced the suppressive capacity of Tregs and thus may also indirectly have contributed to 
wound healing. Thus, in two ways may have contributed to tissue repair (Figure 1). 
 
The function of regulatory T-cell derived Amphiregulin: 
In a similar way, it is possible that Treg-derived Amphiregulin could induce the local release of 
bio-active TGFβ and in this way the differentiation of tissue precursor cells; thus, may 
directly be contributing to tissue repair. Nevertheless, while Tregs have to be considered the 
most prominent cell type mediating local immune regulation, Tregs are not the only 
Amphiregulin-producing cells within inflamed tissues; but, a wide range of other prominent 
Amphiregulin-producing cell types, such as eosinophils, have been shown before to also 
critically contributing to the process of wound healing 49.  
Such a redundancy of cell types, which all could be potentially physiological relevant 
sources of Amphiregulin within injured tissues, raises the question what specific function 
Treg-derived Amphiregulin might have. Amphiregulin expressing Tregs are typically restricted 
to tissue resident Treg populations and thus suggest an organ-specific role for Treg-expressed 
Amphiregulin 21. These tissue resident Treg populations also preferentially express the IL-33 
receptor, T1/ST2 6, 50, 51. The role of T1/ST2 expression on Tregs currently remains 
unresolved. However, IL-33 is an important alarmin, released by dying cells and recent data 
strongly suggest that IL-33 signalling in Tregs provides a critical signal for Treg accumulation 
and maintenance in inflamed tissues 6, 50, 52, 53. However, also how IL-33 may contribute to 
such an expansion of Treg populations at the site of inflammation remains largely unknown. 
We have shown before that the EGFR forms hetero-complexes with T1/ST2 on Th2 cells 43. 
These hetero-complexes allowed Th2 cells to efficiently activate the MAPK signalling 
pathway and thus to induce the expression of IL-13 upon exposure to IL-33 43 (Figure 4). In 
CD4 T-cells, it has been shown that EGFR is one of the most prominently up-regulated 
trans-membrane receptors upon STAT5 activation 54. We showed that both in Th2 cells as 
well as in Tregs the EGFR is strongly up-regulated upon activation 32, 43. Also kinome profiling 
in human Tregs revealed that the EGFR is one of the strongest up-regulated kinases upon 
Treg activation 55. In line with these findings, the group of Rosenblum found induced EGFR 
expression in Tregs in a model of skin wounding in mice 12 and lineage-specific deletion of 
EGFR in Tregs resulted in reduced Treg accumulation within the inflamed skin 12. Thus, in this 
respect the phenotype of EGFR- and T1/ST2-deficient Tregs resembles each other, with both 
depicting a deficiency to expand at the site of inflammation. 
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These findings provide a scenario in which similar to Th2 cells also on Tregs T1/ST2 and the 
EGFR could form hetero-complexes that may allow for IL-33 induced activation of the MAPK 
signalling pathway (Figure 4). The MAPK signalling pathway is a pivotal signalling pathway 
for the transduction of mitogenic stimuli 41, 56. Thus, such an IL-33 mediated activation of the 
MAPK signalling pathway might therefore be a possible mechanism that may explain for the 
observed expansion of tissue resident Treg populations upon injection of rIL-33 50, 52.  
Such hetero-complexes between the EGFR and T1/ST2 on tissue resident Tregs could further 
enable these cells to become activated in a TCR independent way, as we have 
demonstrated before for Th2 cells 43. Upon tissue damage, antigen-specific restimulation of 
tissue resident Treg populations via MHC-II antigen presentation and TCR-mediated 
activation might not always be possible. Thus, the recognition of released IL-33 from 
damaged tissues may constitute an alternative pathway of activation for tissue-resident Treg 
populations. Such an assumption is further supported by a study using a NOD based model 
of auto-immune diabetes. This study demonstrated that in specific Treg populations with a 
low-affinity TCR for their cognate antigen preferentially expressed Amphiregulin, 
preferentially localized to the site of inflammation and functioned there in an antigen-
independent way 57. Thus, taken together, the combined expression of T1/ST2 and EGFR 
may enable tissue-resident Treg populations to function in a MHC-II independent way. 
In Th2 cells, the induced expression of Amphiregulin, in an autocrine way, enabled the 
formation of such hetero-complexes between EGFR and T1/ST2, and only upon expression 
of Amphiregulin could activated Th2 cells function in a MHC-II independent way 43. 
Assuming a similar function for Amphiregulin in tissue resident Treg populations, then the 
constitutive expression of Amphiregulin may keep these Tregs in a “poised” state (Figure 4). 
In such a “poised” state tissue resident Treg populations would be able to rapidly respond to 
tissue damage and the exposure to IL-33.  
Such a poised state of tissue resident Treg populations could be critical during tissue injury, 
for instance due to the fact that IL-33 release from necrotic cells is a very early event during 
tissue injury in many tissues. Thus, this poised state may allow to already inducing the 
activation and expansion of Treg populations at the site of injury, while the infiltration of Treg 
populations derived from secondary lymphoid organs into injured tissues may so far not 
have been initiated yet 5, 6. Thus, the constitutive expression of Amphiregulin by tissue-
resident Tregs may constitute a first line of defence during wounding. However, also under 
steady state conditions, such a “poised” state of tissue resident Treg populations could be 
contributing to tissue homeostasis; for instance in fatty tissues, in which a constant, IL-33 
dependent but most likely antigen-independent activation of Treg populations contributes to 
the control of local and systemic inflammation and metabolism. 
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Summary and out-look: 
Taken together, a wide range of different publications in recent years strongly suggested 
that Tregs play an important role in wound healing, both by suppressing local inflammation 
and also by directly contributing to the wound healing process. The exact mechanism of how 
Tregs contribute to these processes has remained to be resolved and further research is 
necessary to fully resolve the specific function of Treg-derived Amphiregulin. At this stage, it 
remains speculative to which extent Treg-derived Amphiregulin main function might be to 
directly contribute to wound healing, and to which extent it contributes to the local release of 
bioactive TGFβ, which then has both a wound healing and immune suppressive function at 
the site of injury.  
However, alternatively, Treg-derived Amphiregulin may also contribute to the survival and 
expansion of tissue-resident Tregs upon injury. Since it was also further shown that T1/ST2 
expressing Treg populations preferentially express high levels of integrin-αV and low levels of 
IL-10 51, it is tempting to speculate that this constitutive expression of Amphiregulin by 
tissue-resident Tregs may also lead to a constitutive, low level release of bio-active TGFβ, 
which may contribute to on-going regeneration of tissues and to a low level immune 
suppressive environment in the surrounding of Amphiregulin-expressing tissue resident Treg 
populations, which might be an evolutionary advantage for instance in inflammation prone 
tissues, such as fatty tissues. 
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Figure 1: 
 
 
 
 
Figure 1: Dual function of regulatory T-cells during wound healing. 
The process of wound healing has to be well orchestrated and disruption of this process, for 
instance due to the infection of the healing wound, can lead to a failure of wound healing or 
excessive scar formation. Regulatory T-cells rapidly accumulate at sites of injury and keep 
local immune responses under control so that no excessive immune responses develop that 
could cause additional damage. This immune regulatory, “damage-limiting” function of 
regulatory T-cells is complemented by an immune independent, “damage-resolving” direct 
role in wound healing. In this process, regulatory T-cells at the site of injury release growth 
factors, such as the EGF-like growth factor Amphiregulin, that directly contribute to the 
proliferation and differentiation of cells within the injured tissues; in this way, contributing to 
wound healing and the restoration of tissue homeostasis.  
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Figure 2: Amphiregulin contributes to wound healing by releasing local, bioactive 
TGFβ 
Upon tissue damage, tissue-resident macrophages sense the breach of tissue homeostasis 
and release Amphiregulin, which activates the local release of bio-active TGFβ. This local 
release of bio-active TGFβ induces the differentiation of local pericyte populations into 
myofibroblasts, which produce extra-cellular matrix components essential for the restoration 
of blood barrier function and the restoration of tissue homeostasis.  
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Figure 3: Amphiregulin induces an “inside-out” activation of integrin complexes that 
then lead to the local release of bioactive TGFβ. 
Amphiregulin induces a sustained PLCγ-mediated signal via the Epidermal Growth Factor 
Receptor (EGFR). Such a sustained PLCγ-mediated signalling induces an intra-cellular 
rearrangement of local actin fibers and the physical separation of complexed, trans-
membrane integrin-α and integrin-β subunits and thus to their extra-cellular activation. Such 
an “inside-out” activation of integrin-αV containing complexes can induce the local release of 
bio-active TGFβ from its latent form, and thus to the local activation of the TGFβ signalling 
pathway. 
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Figure 4: An Amphiregulin-mediated autocrine activation of the EGFR facilitates T-
cells to form a hetero-complex with the IL-33R (T1/ST2), which enables IL-33 to 
activate the MAP-kinase signalling pathway. 
The low-affinity EGFR ligand Amphiregulin activates resting EGFR complexes. This places 
the receptor into a “poised state”, which allows it to enter “signalling competent” clusters on 
the cell surface and to interact with the IL-33R (T1/ST2). Such clusters of hetero-complexes 
between the EGFR and T1/ST2 then enables IL-33 to mediate a MAP-kinase mediated 
signal via the EGFR, and thus potentially the proliferation of tissue-resident regulatory T-cell 
populations. 
 
 
 
 
 
